{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AMPK", "NLRP3 inflammasome", "acute lung injury", "macrophages", "mitochondrial damage", "tiliroside"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38005247", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "10"}], "Language": ["eng"], "ELocationID": ["7527", "10.3390/molecules28227527"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "22", "PubDate": {"Year": "2023", "Month": "Nov", "Day": "10"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Tiliroside Attenuates NLRP3 Inflammasome Activation in Macrophages and Protects against Acute Lung Injury in Mice.", "Abstract": {"AbstractText": ["The Nod-like receptor family PYRIN domain containing 3 (NLRP3) inflammasome is a multiprotein signaling complex that plays a pivotal role in innate immunity, and the dysregulated NLRP3 inflammasome activation is implicated in various diseases. Tiliroside is a natural flavonoid in multiple medicinal and dietary plants with known anti-inflammatory activities. However, its role in regulating NLRP3 inflammasome activation and NLRP3-related disease has not been evaluated. Herein, it was demonstrated that tiliroside is inhibitory in activating the NLRP3 inflammasome in macrophages. Mechanistically, tiliroside promotes AMP-activated protein kinase (AMPK) activation, thereby leading to ameliorated mitochondrial damage as evidenced by the reduction of mitochondrial reactive oxygen species (ROS) production and the improvement of mitochondrial membrane potential, which is accompanied by attenuated NLRP3 inflammasome activation in macrophages. Notably, tiliroside potently attenuated lipopolysaccharide (LPS)-induced acute lung injury in mice, which has been known to be NLRP3 inflammasome dependent. For the first time, this study identified that tiliroside is an NLRP3 inflammasome inhibitor and may represent a potential therapeutic agent for managing NLRP3-mediated inflammatory disease."]}, "AuthorList": [{"Identifier": ["0009-0007-4780-0696"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Translational Medicine, College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Zhong", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Translational Medicine, College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Yang", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Translational Medicine, College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Deng", "ForeName": "Keke", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Translational Medicine, College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Lang", "ForeName": "Xiaoya", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Translational Medicine, College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Zhang", "ForeName": "Jiangtao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Traditional Chinese Medicine Resources and Ethnic Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Li", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Translational Medicine, College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Qiu", "ForeName": "Liang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Traditional Chinese Medicine Resources and Ethnic Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China."}], "LastName": "Zhong", "ForeName": "Guoyue", "Initials": "G"}, {"Identifier": ["0000-0003-4530-2179"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiovascular Sciences, Center for Metabolic Disease Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA."}], "LastName": "Yu", "ForeName": "Jun", "Initials": "J"}], "GrantList": [{"GrantID": "82104180", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "GJJ2200909", "Agency": "Key Program for Science and Technology Projects of the Education Department of Jiangxi Province", "Country": ""}, {"GrantID": "20212BAB216012", "Agency": "Jiangxi Provincial Natural Science Foundation", "Country": ""}, {"GrantID": "20202BCD42014", "Agency": "Jiangxi Key Laboratory of Traditional Chinese Medicine", "Country": ""}, {"GrantID": "ZXYYLXK20220103", "Agency": "Jiangxi University of Chinese Medicine", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Inflammasomes"}, {"RegistryNumber": "0", "NameOfSubstance": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"RegistryNumber": "15M04TXR9M", "NameOfSubstance": "tiliroside"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammasomes"}, {"QualifierName": ["metabolism"], "DescriptorName": "NLR Family, Pyrin Domain-Containing 3 Protein"}, {"QualifierName": ["metabolism"], "DescriptorName": "Macrophages"}, {"QualifierName": ["metabolism"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["metabolism"], "DescriptorName": "Acute Lung Injury"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Martinon F., Mayor A., Tschopp J. The inflammasomes: Guardians of the body. Annu. Rev. Immunol. 2009;27:229\u2013265. doi: 10.1146/annurev.immunol.021908.132715.", "ArticleIdList": ["10.1146/annurev.immunol.021908.132715", "19302040"]}, {"Citation": "Kelley N., Jeltema D., Duan Y., He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci. 2019;20:3328. doi: 10.3390/ijms20133328.", "ArticleIdList": ["10.3390/ijms20133328", "PMC6651423", "31284572"]}, {"Citation": "Paik S., Kim J.K., Silwal P., Sasakawa C., Jo E.-K. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell. Mol. Immunol. 2021;18:1141\u20131160. doi: 10.1038/s41423-021-00670-3.", "ArticleIdList": ["10.1038/s41423-021-00670-3", "PMC8093260", "33850310"]}, {"Citation": "Swanson K.V., Deng M., Ting J.P.-Y. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 2019;19:477\u2013489. doi: 10.1038/s41577-019-0165-0.", "ArticleIdList": ["10.1038/s41577-019-0165-0", "PMC7807242", "31036962"]}, {"Citation": "Davis B.K., Wen H., Ting J.P.-Y. The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases. Annu. Rev. Immunol. 2011;29:707\u2013735. doi: 10.1146/annurev-immunol-031210-101405.", "ArticleIdList": ["10.1146/annurev-immunol-031210-101405", "PMC4067317", "21219188"]}, {"Citation": "Jo E.-K., Kim J.K., Shin D.-M., Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 2016;13:148\u2013159. doi: 10.1038/cmi.2015.95.", "ArticleIdList": ["10.1038/cmi.2015.95", "PMC4786634", "26549800"]}, {"Citation": "Zahid A., Li B., Kombe A.J.K., Jin T., Tao J. Pharmacological Inhibitors of the NLRP3 Inflammasome. Front. Immunol. 2019;10:2538. doi: 10.3389/fimmu.2019.02538.", "ArticleIdList": ["10.3389/fimmu.2019.02538", "PMC6842943", "31749805"]}, {"Citation": "Weber A., Wasiliew P., Kracht M. Interleukin-1 (IL-1) Pathway. Sci. Signal. 2010;3:cm1. doi: 10.1126/scisignal.3105cm1.", "ArticleIdList": ["10.1126/scisignal.3105cm1", "20086235"]}, {"Citation": "Weber A., Wasiliew P., Kracht M. Interleukin-1beta (IL-1beta) processing pathway. Sci. Signal. 2010;3:cm2.", "ArticleIdList": ["20086236"]}, {"Citation": "Chousterman B.G., Swirski F.K., Weber G.F. Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol. 2017;39:517\u2013528. doi: 10.1007/s00281-017-0639-8.", "ArticleIdList": ["10.1007/s00281-017-0639-8", "28555385"]}, {"Citation": "Pan P., Shen M., Yu Z., Ge W., Chen K., Tian M., Xiao F., Wang Z., Wang J., Jia Y., et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat. Commun. 2021;12:4664. doi: 10.1038/s41467-021-25015-6.", "ArticleIdList": ["10.1038/s41467-021-25015-6", "PMC8329225", "34341353"]}, {"Citation": "Sanchez-Lopez E., Zhong Z., Stubelius A., Sweeney S.R., Booshehri L.M., Antonucci L., Liu-Bryan R., Lodi A., Terkeltaub R., Lacal J.C., et al. Choline Uptake and Metabolism Modulate Macrophage IL-1\u03b2 and IL-18 Production. Cell Metab. 2019;29:1350\u20131362.e7. doi: 10.1016/j.cmet.2019.03.011.", "ArticleIdList": ["10.1016/j.cmet.2019.03.011", "PMC6675591", "30982734"]}, {"Citation": "Danielski L.G., Della Giustina A., Bonfante S., Barichello T., Petronilho F. The NLRP3 Inflammasome and Its Role in Sepsis Development. Inflammation. 2020;43:24\u201331. doi: 10.1007/s10753-019-01124-9.", "ArticleIdList": ["10.1007/s10753-019-01124-9", "31741197"]}, {"Citation": "Bagherniya M., Khedmatgozar H., Fakheran O., Xu S., Johnston T.P., Sahebkar A. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome. Phytother. Res. 2021;35:4804\u20134833. doi: 10.1002/ptr.7118.", "ArticleIdList": ["10.1002/ptr.7118", "33856730"]}, {"Citation": "Yang J., Zhong C., Yu J. Natural Monoterpenes as Potential Therapeutic Agents against Atherosclerosis. Int. J. Mol. Sci. 2023;24:2429. doi: 10.3390/ijms24032429.", "ArticleIdList": ["10.3390/ijms24032429", "PMC9917110", "36768748"]}, {"Citation": "Grochowski D.M., Locatelli M., Granica S., Cacciagrano F., Tomczyk M. A Review on the Dietary Flavonoid Tiliroside. Compr. Rev. Food Sci. Food Saf. 2018;17:1395\u20131421. doi: 10.1111/1541-4337.12389.", "ArticleIdList": ["10.1111/1541-4337.12389", "33350157"]}, {"Citation": "Jin X., Song S., Wang J., Zhang Q., Qiu F., Zhao F. Tiliroside, the major component of Agrimonia pilosa Ledeb ethanol extract, inhibits MAPK/JNK/p38-mediated inflammation in lipopolysaccharide-activated RAW 264.7 macrophages. Exp. Ther. Med. 2016;12:499\u2013505. doi: 10.3892/etm.2016.3305.", "ArticleIdList": ["10.3892/etm.2016.3305", "PMC4906937", "27347085"]}, {"Citation": "Velagapudi R., Aderogba M., Olajide O.A. Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-\u03baB/p38-mediated neuroinflammation in activated BV2 microglia. Biochim. Biophys. Acta. 2014;1840:3311\u20133319. doi: 10.1016/j.bbagen.2014.08.008.", "ArticleIdList": ["10.1016/j.bbagen.2014.08.008", "25152356"]}, {"Citation": "Velagapudi R., El-Bakoush A., Olajide O.A. Activation of Nrf2 Pathway Contributes to Neuroprotection by the Dietary Flavonoid Tiliroside. Mol. Neurobiol. 2018;55:8103\u20138123. doi: 10.1007/s12035-018-0975-2.", "ArticleIdList": ["10.1007/s12035-018-0975-2", "PMC6132780", "29508282"]}, {"Citation": "Sala A., Recio M., Schinella G.R., M\u00e1\u00f1ez S., Giner R.M., Cerd\u00e1-Nicol\u00e1s M., R\u00edos J.-L. Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside. Eur. J. Pharmacol. 2003;461:53\u2013611. doi: 10.1016/S0014-2999(02)02953-9.", "ArticleIdList": ["10.1016/S0014-2999(02)02953-9", "12568916"]}, {"Citation": "Zhuang H., Lv Q., Zhong C., Cui Y., He L., Zhang C., Yu J. Tiliroside Ameliorates Ulcerative Colitis by Restoring the M1/M2 Macrophage Balance via the HIF-1\u03b1/glycolysis Pathway. Front. Immunol. 2021;12:649463. doi: 10.3389/fimmu.2021.649463.", "ArticleIdList": ["10.3389/fimmu.2021.649463", "PMC8044352", "33868286"]}, {"Citation": "Nagar A., Rahman T., Harton J.A. The ASC Speck and NLRP3 Inflammasome Function Are Spatially and Temporally Distinct. Front. Immunol. 2021;12:752482. doi: 10.3389/fimmu.2021.752482.", "ArticleIdList": ["10.3389/fimmu.2021.752482", "PMC8566762", "34745125"]}, {"Citation": "Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221\u2013225. doi: 10.1038/nature09663.", "ArticleIdList": ["10.1038/nature09663", "21124315"]}, {"Citation": "Liu Q., Zhang D., Hu D., Zhou X., Zhou Y. The role of mitochondria in NLRP3 inflammasome activation. Mol. Immunol. 2018;103:115\u2013124. doi: 10.1016/j.molimm.2018.09.010.", "ArticleIdList": ["10.1016/j.molimm.2018.09.010", "30248487"]}, {"Citation": "Mishra S.R., Mahapatra K.K., Behera B.P., Patra S., Bhol C.S., Panigrahi D.P., Praharaj P.P., Singh A., Patil S., Dhiman R., et al. Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics. Int. J. Biochem. Cell Biol. 2021;136:106013. doi: 10.1016/j.biocel.2021.106013.", "ArticleIdList": ["10.1016/j.biocel.2021.106013", "34022434"]}, {"Citation": "Wu S., Zou M.H. AMPK, Mitochondrial Function, and Cardiovascular Disease. Int. J. Mol. Sci. 2020;21:4987. doi: 10.3390/ijms21144987.", "ArticleIdList": ["10.3390/ijms21144987", "PMC7404275", "32679729"]}, {"Citation": "Feng Y., Li M., Yangzhong X., Zhang X., Zu A., Hou Y., Li L., Sun S. Pyroptosis in inflammation-related respiratory disease. J. Physiol. Biochem. 2022;78:721\u2013737. doi: 10.1007/s13105-022-00909-1.", "ArticleIdList": ["10.1007/s13105-022-00909-1", "PMC9684248", "35819638"]}, {"Citation": "Hoss F., Rolfes V., Davanso M.R., Braga T.T., Franklin B.S. Detection of ASC Speck Formation by Flow Cytometry and Chemical Cross-linking. Methods Mol. Biol. 2018;1714:149\u2013165.", "ArticleIdList": ["29177861"]}, {"Citation": "Wu K., Yuan Y., Yu H., Dai X., Wang S., Sun Z., Wang F., Fei H., Lin Q., Jiang H., et al. The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice. Blood. 2020;136:501\u2013515. doi: 10.1182/blood.2019003990.", "ArticleIdList": ["10.1182/blood.2019003990", "PMC7378459", "32291445"]}, {"Citation": "Tian J., Chang S., Wang J., Chen J., Xu H., Huang T., Wang J., Kang J., Fan W., Wang Y. S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis. Mol. Immunol. 2023;160:55\u201366. doi: 10.1016/j.molimm.2023.06.006.", "ArticleIdList": ["10.1016/j.molimm.2023.06.006", "37379683"]}, {"Citation": "Zhang J., Liu X., Wan C., Liu Y., Wang Y., Meng C., Zhang Y., Jiang C. NLRP3 inflammasome mediates M1 macrophage polarization and IL-1\u03b2 production in inflammatory root resorption. J. Clin. Periodontol. 2020;47:451\u2013460. doi: 10.1111/jcpe.13258.", "ArticleIdList": ["10.1111/jcpe.13258", "31976565"]}, {"Citation": "Gro\u00df C.J., Mishra R., Schneider K.S., M\u00e9dard G., Wettmarshausen J., Dittlein D.C., Shi H., Gorka O., Koenig P.A., Fromm S., et al. K(+) Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria. Immunity. 2016;45:761\u2013773. doi: 10.1016/j.immuni.2016.08.010.", "ArticleIdList": ["10.1016/j.immuni.2016.08.010", "27692612"]}, {"Citation": "Yeon S.H., Yang G., Lee H.E., Lee J.Y. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages. J. Leukoc. Biol. 2017;101:205\u2013215. doi: 10.1189/jlb.3VMA1215-579RR.", "ArticleIdList": ["10.1189/jlb.3VMA1215-579RR", "27256568"]}, {"Citation": "Bedient L., Pokharel S.M., Chiok K.R., Mohanty I., Beach S.S., Miura T.A., Bose S. Lytic Cell Death Mechanisms in Human Respiratory Syncytial Virus-Infected Macrophages: Roles of Pyroptosis and Necroptosis. Viruses. 2020;12:932. doi: 10.3390/v12090932.", "ArticleIdList": ["10.3390/v12090932", "PMC7552060", "32854254"]}, {"Citation": "Alves J.V., da Costa R.M., Pereira C.A., Fedoce A.G., Silva C.A.A., Carneiro F.S., Lobato N.S., Tostes R.C. Supraphysiological Levels of Testosterone Induce Vascular Dysfunction via Activation of the NLRP3 Inflammasome. Front. Immunol. 2020;11:1647. doi: 10.3389/fimmu.2020.01647.", "ArticleIdList": ["10.3389/fimmu.2020.01647", "PMC7411079", "32849566"]}, {"Citation": "Dai J., Zhang X., Wang Y., Chen H., Chai Y. ROS-activated NLRP3 inflammasome initiates inflammation in delayed wound healing in diabetic rats. Int. J. Clin. Exp. Pathol. 2017;10:9902\u20139909.", "ArticleIdList": ["PMC6965894", "31966879"]}, {"Citation": "Yue H., Yang Z., Ou Y., Liang S., Deng W., Chen H., Zhang C., Hua L., Hu W., Sun P. Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation. Int. Immunopharmacol. 2021;97:107819. doi: 10.1016/j.intimp.2021.107819.", "ArticleIdList": ["10.1016/j.intimp.2021.107819", "34098486"]}, {"Citation": "Deng Z., Ni J., Wu X., Wei H., Peng J. GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway. Aging. 2020;12:18522\u201318544. doi: 10.18632/aging.103825.", "ArticleIdList": ["10.18632/aging.103825", "PMC7585118", "32950971"]}, {"Citation": "Zhang H., Gong X., Ni S., Wang Y., Zhu L., Ji N. C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway. Int. Immunopharmacol. 2019;77:105934. doi: 10.1016/j.intimp.2019.105934.", "ArticleIdList": ["10.1016/j.intimp.2019.105934", "31727560"]}, {"Citation": "Tang G., Duan F., Li W., Wang Y., Zeng C., Hu J., Li H., Zhang X., Chen Y., Tan H. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE(\u2212/\u2212) mice. Biomed. Pharmacother. Biomed. Pharmacother. 2019;119:109410. doi: 10.1016/j.biopha.2019.109410.", "ArticleIdList": ["10.1016/j.biopha.2019.109410", "31518877"]}, {"Citation": "Rabinovitch R.C., Samborska B., Faubert B., Ma E.H., Gravel S.-P., Andrzejewski S., Raissi T.C., Pause A., St.-Pierre J., Jones R.G. AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species. Cell Rep. 2017;21:1\u20139. doi: 10.1016/j.celrep.2017.09.026.", "ArticleIdList": ["10.1016/j.celrep.2017.09.026", "28978464"]}, {"Citation": "Broz P., Dixit V.M. Inflammasomes: Mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 2016;16:407\u2013420. doi: 10.1038/nri.2016.58.", "ArticleIdList": ["10.1038/nri.2016.58", "27291964"]}, {"Citation": "Jiang R., Xu J., Zhang Y., Zhu X., Liu J., Tan Y. Ligustrazine Alleviate Acute Lung Injury Through Suppressing Pyroptosis and Apoptosis of Alveolar Macrophages. Front. Pharmacol. 2021;12:680512. doi: 10.3389/fphar.2021.680512.", "ArticleIdList": ["10.3389/fphar.2021.680512", "PMC8193053", "34122107"]}, {"Citation": "Liu B., Wang Z., He R., Xiong R., Li G., Zhang L., Fu T., Li C., Li N., Geng Q. Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway. Clin. Sci. 2022;136:273\u2013289. doi: 10.1042/CS20211156.", "ArticleIdList": ["10.1042/CS20211156", "35132999"]}, {"Citation": "Ying Y., Mao Y., Yao M. NLRP3 Inflammasome Activation by MicroRNA-495 Promoter Methylation May Contribute to the Progression of Acute Lung Injury. Mol. Ther. Nucleic Acids. 2019;18:801\u2013814. doi: 10.1016/j.omtn.2019.08.028.", "ArticleIdList": ["10.1016/j.omtn.2019.08.028", "PMC6861628", "31734560"]}, {"Citation": "Guo Y., Liu Y., Zhao S., Xu W., Li Y., Zhao P., Wang D., Cheng H., Ke Y., Zhang X. Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages. Nat. Commun. 2021;12:7094. doi: 10.1038/s41467-021-27428-9.", "ArticleIdList": ["10.1038/s41467-021-27428-9", "PMC8651733", "34876574"]}, {"Citation": "Li J., Lu K., Sun F., Tan S., Zhang X., Sheng W., Hao W., Liu M., Lv W., Han W. Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway. J. Transl. Med. 2021;19:96. doi: 10.1186/s12967-021-02745-1.", "ArticleIdList": ["10.1186/s12967-021-02745-1", "PMC7927246", "33653364"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "8"}, {"Year": "2023", "Month": "10", "Day": "31"}, {"Year": "2023", "Month": "11", "Day": "8"}, {"Year": "2023", "Month": "11", "Day": "27", "Hour": "12", "Minute": "44"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "1", "Minute": "26"}, {"Year": "2023", "Month": "11", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["38005247", "PMC10673355", "10.3390/molecules28227527", "molecules28227527"]}}], "PubmedBookArticle": []}